Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy

Circulation

Volumn 97, Issue 10, 1998, Pages 971-978

  Patella, Vincenzo ^a   Marinò, Isabella ^a   Arbustini, Eloisa ^b   Lamparter Schummert, Bärbel ^c   Versa, Laura ^b   Adt, Monika ^c   Marone, Gianni ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiomyopathy; Cells; Fibrosis; Leukotrienes; Mast

Indexed keywords

CALCIMYCIN; COLLAGEN; HISTAMINE; IMMUNOGLOBULIN E; LEUKOTRIENE C4; STEM CELL FACTOR; TRYPTASE;

ADULT; ARTICLE; AUTOCRINE EFFECT; CELL DENSITY; CELL HYPERPLASIA; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MALE; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; SECRETORY GRANULE;

EID: 0032539897     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.10.971     Document Type: Article

References (52)

1. Galli JS. New concepts about the mast cells. N Engl J Med. 1993;328:- 257-265.
2. Dvorak AM. Mast-cell degranulation in human hearts. N Engl J Med. 1986;315:969-970.
3. Spert WR, Bankl HC, Mundigler G, Klappacher G, Großschmidt K, Agis H, Simon P, Laufer P, Imohof M, Radaszkiewicz Th, Glogar D, Lechner K, Valent P. The human cardiac mast cell: localization, isolation, phenotype, functional characterization. Blood. 1994;84:3876-3884.
4. Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm. Science. 1984;223:1435-1437.
5. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R. Increased advenritial mast cells in a patient with coronary spasm. N Engl J Med. 1985;313:1138-1141.
6. Kaartinen M, Penttilä A, Kovanen PT. Mast cells of two types differing in neutral protease composition in the human aortic intima: demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and in shoulder region of atheromas. Arterioscler Thromb. 1994;14:966-972.
7. Marone G, Triggiani M, Cirillo R, Giacummo A, Hammarström S, Condorelli M. IgE-mediated activation of human heart in vitro. Agents Actions. 1986;18:194-196.
8. Graver LM, Robertson DA, Levi R, Becker CG, Weksler BB, Gay WA. IgE-mediated hypersensitivity in human heart tissue: histamine release and functional changes. J Allergy Clin Immunol. 1986;77:709-714.
9. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 1995;92:1084-1088.
10. Vigorito C, Russo P, Picotti GB, Chiariello M, Poto S, Marone G. Cardiovascular effects of histamine infusion in man. J Cardiovasc Phamocol. 1983;5:531-537.
11. 1 receptor on coronary hemodynamics in man. Circulation. 1986;73:1175-1182.
12. Marone G, Giordano A, Cirillo R, Triggiani M, Vigorito C. Cardiovascular and metabolic effects of peptide leukotrienes in man. Ann N Y Acad Sci. 1988;524:321-323.
13. Criqui MH, Lee ER, Hamburger RN, Klauber MR, Coughlin SS. IgE and cardiovascular disease. Am J Med. 1987;82:964-968.
14. Szczeklik A, Sladek K, Szczerba A. Serum immunoglobulin E response to myocardial infarction. Circulation. 1988;77:1245-1249.
15. Levi R, Malm JR, Bowman FO, Rosen MR. The arrhythmogenic actions of histamine on human atrial fibers. Circ Res. 1981;49:545-550.
16. Vigorito C, Marone G, Condorelli M. Cardiovascular effects of histamine and sulfidopeptide leukotrienes. In: Marone G, Lichtenstein LM, Condorelli M, Fauci AS, eds. Human Inflammatory Disease: Clinical Immunology, Vol 1. Toronto, Canada/ Philadelphia, Pa: BC Decker, 1988.
17. Mukherjee D. Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. J Clin Invest. 1991;88:1141-1146.
18. Seibold JR, Giorno RC, Claman HN. Dermal mast cell degranulation in systemic sclerosis. Arthrit Rheum. 1990;33:1702-1709.
19. Kawanami O, Ferrans VJ, Fulmer JD, Crystal RG. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest. 1979;40:717-734.
20. Fernex M. The Mast-Cell System: Its Relationship to Atherosclerosis, Fibrosis and Eosinophils. Baltimore. Md: Williams & Wilkins; 1968.
21. Estensen R. Eosmophilic myocarditis: a role for mast cells? Arch Pathol Lab Med. 1984;108:358-359.
22. Patella V, de Crescenzo G, Marino I, Genovese A, Adt M, Gleich GJ, Marone G. Eosinophil granule proteins activate human heart mast cells. J Immunol. 1996;157:1219-1225.
23. Lichtbroun AS, Sandhaus LM, Giorno RC, Kim H, Seibold JR. Myocardial mast cells in systemic sclerosis: a report of three fatal cases. Am J Med. 1990;89:372-376.
24. Patella V, Marino I, Lamparter B, Arbustini E, Adt M, Marone G. Human heart mast cells: isolation, purification, ultrastructure, and immunologic characterization. J Immunol. 1995;154:2855-2865.
25. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, Galli SJ. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A. 1991;88:6382-6386.
26. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr. Bochner BS, Gillis S, Zsebo KM, Galli S, Lichtenstein LM. The human recombinant c-kit receptor ligand, rhSCK, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.J Immunol2E 1992;149:599-608.
27. Nilsson G, Miettinen U, Ishizaka T, Ashman LK, Irani A-M, Schwanz LB. Interleukin-4 inhibits the expression of kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood. 1994;84:1519-1527.
28. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Haves DF, Merica EA, Menchaca DM, Gringeri AJ, Schwanz LB, Galli SJ. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med. 1996;183:2681-2686.
29. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Virginia VM, Walter HA, Harlan WR. Prevalance and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop). Am J Cardiol. 1992;69:1458-1466.
30. Grasso M, Arbustini E, Silini E, Diegoli M, Percivale E, Ratti G, Bramerio M, Gavazzi A, Viganò M, Milanesi G. Search for coxsackie virus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol. 1992;69:658-664.
31. Kusner EJ, Marks RL, Aharony D, Krell RD. Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro. Biochem Pharmacol. 1989;38:4183-4189.
32. de Paulis A, Marinò I, Ciccarelli A, de Crescenzo G, Concardi M, Verga L, Arbustini E, Marone G. Human synovial mast cells, I: ultrastructure in situ and in vitro immunologic characterization. Arthrit Rheum. 1996;39:1222-1233.
33. Siraganian RP. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem. 1974;57:383-394.
34. Arbustini E, Pucci A, Grasso M, Diegoli M, Pozzi R, Gavazzi A, Graziano G, Campana, Goggi, Martinelli, Sini E, Specchia G, Viganò M, Solcia E. Expression of natriuretic peptide in ventricular myocardium of failing human hearts and its correlation with the severity of clinical and hemodynamic impairment. Am J Cardiol. 1990;66:973-980.
35. Snedecor GW, Cochran WG, Statistical Methods. Ames, Iowa: The Iowa State University Press: 1980.
36. Valent P, Spanblöchl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, Strobl H, Geissler K, Bettelheim P, Lechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood. 1992;9:2237-2245.
37. de Paulis A, Ciccarelli A, Cirillo R, de Crescenzo G, Columbo M, Marone G. Modulation of human lung mast cell function by the c-kit receptor ligand. Int Arch Allergy Immunol. 1992;99:326-329.
38. Schwartz LB, Irani AA, Roller K, Castells MC, Schlechter NM. Quanti- tation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 1987;138:2611-2615.
39. Hartman T, Ruoss SJ, Raymond WW, Seuwem K, Caughey GH. Human tryptase as a potent, cell-specific mitogen: role of signaling pathways in synergistic responses. Am J Physiol. 1992;262:L528-L534.
40. Baud L, Perez J, Denis M, Ardaillou R. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin.J Immunol. 1987;138:1190-1195.
41. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A. 1991;88:4220-4224.
42. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST. Interlcukin 4 is localized to and released by human mast cells. J Exp Med. 1992;176:1381-1386.
43. Kovanen PT. Role of mast cells in atherosclerosis. In: Marone G, ed. Human Basophils and Mast Cells: Clinical Aspects. Basel, Switzerland: Karger; 1995:132-165.
44. Russell JD, Russell SB, Trupin KM. The effect of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue. J Cell Physiol. 1977;93:389-394.
45. Hatamochi A, Fujiwarw K, Ueki H. Effects of histamine on collagen synthesis by cultured fibroblast derived from guinea pig skin. Arch Dermatol Res. 1985;277:60-64.
46. d mutant. Cell. 1991;64:1025-1035.
47. Longley BJ Jr, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE, Halaban R. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med. 1993;328:1302-1307.
48. Heinrich MC, Dooley DC, Freed AC, Band L, Hoatlin ME, Keeble WW, Peters ST, Silvey KV, Ey FS, Kabat D, Maziarz RT, Bagby GC Jr. Constitutive expression of steel factor gene by human stromal cells. Blood. 1993;82:771-783.
49. Beck D, Gross N, Beretta Brognara C, Perruiseau G. Expression of stem cell factor and its receptor by human neuroblastoma cells tumors. Blood. 1995;86:3132-3138.
50. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs SV, Martin FH, Williams DA. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci U S A. 1992;89:7350-7354.
51. Huang EJ, Nocka KH, Bruck J, Besmer P. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell. 1992;3:349-362.
52. Shimizu Y, Ashman LK, Du Z, Schwartz LB. Internalization of kit together with stem cell factor on human fetal liver-derived mast cells. J Immunol. 1996;156:3443-3449.